Search results for “Blepharitis” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 505 patents, we discovered top 97 key players by total patent application. Novartis AG, Kala Pharmaceuticals, Inc., Tarsus Pharmaceuticals, Inc. are dominant in this area. They take 19.21% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 35
Kala Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 33
Tarsus Pharmaceuticals, Inc.
California, United States
Patent: 29
STARTUP
Azura Ophthalmics Ltd.
Israel
Patent: 21
Senju Pharmaceutical Beijing Co. Ltd.
Beijing Shi, China
Patent: 21
Inspire Pharmaceuticals, Inc.
North Carolina, United States
Patent: 17
Senju-USA, Inc.
California, United States
Patent: 14
Allergan, Inc.
California, United States
Patent: 12
SIFI SpA
Lombardia, Italy
Patent: 10
Novaliq GmbH
Baden-Württemberg, Germany
Patent: 10
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 28 patents, we discovered top 4 start-ups by total patent application. Azura Ophthalmics Ltd., Glia LLC, Cloudbreak Therapeutics LLC are active in this area.
STARTUP
Azura Ophthalmics Ltd.
Israel
Patent: 21
STARTUP
Glia LLC
Indiana, United States
Patent: 4
STARTUP
Cloudbreak Therapeutics LLC
California, United States
Patent: 2
STARTUP
Resono Ophthalmic SRL
Italy
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 225 patents applied in the last 5 years. We discover 46 most active companies in this area. The fast-growing Tarsus Pharmaceuticals, Inc., Azura Ophthalmics Ltd., Kala Pharmaceuticals, Inc. take 27.11% of patent filing during this period.
Tarsus Pharmaceuticals, Inc.
California, United States
Patent: 28
STARTUP
Azura Ophthalmics Ltd.
Israel
Patent: 21
Kala Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 12
Premark Pharma GmbH
Switzerland
Patent: 10
Novoxel Ltd.
Israel
Patent: 8
ADS Therapeutics LLC
United States
Patent: 7
Ripple Therapeutics Corp.
Ontario, Canada
Patent: 6
Sight Sciences, Inc.
California, United States
Patent: 4
SIFI SpA
Lombardia, Italy
Patent: 4
Probiotical SpA
Piemonte, Italy
Patent: 4
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 225 patents in last 5 years, we discover 32 new entrants. Azura Ophthalmics Ltd., Premark Pharma GmbH, Novoxel Ltd. are the most active new entrants in this area.
STARTUP
Azura Ophthalmics Ltd.
Israel
Patent: 21
Premark Pharma GmbH
Switzerland
Patent: 10
Novoxel Ltd.
Israel
Patent: 8
ADS Therapeutics LLC
United States
Patent: 7
Ripple Therapeutics Corp.
Ontario, Canada
Patent: 6
Sight Sciences, Inc.
California, United States
Patent: 4
Probiotical SpA
Piemonte, Italy
Patent: 4
STARTUP
Glia LLC
Indiana, United States
Patent: 4
Sol-Gel Technologies Ltd.
Israel
Patent: 3
Samsung Life Public Welfare Foundation
South Korea
Patent: 3
Research Institutions
Order by:
Innovation Intensity
With the analysis among 16 patents, we discovered top 6 universities and scientific research institutions by total patent application. Vanderbilt University, The University of Sydney, Xiamen University are dominant in this area. They take 31.25% of the total patent filing.
Vanderbilt University
Tennessee, United States
Patent: 2
The University of Sydney
Australia
Patent: 1
Xiamen University
Fujian Sheng, China
Patent: 1
Korea Institute of Science & Technology
South Korea
Patent: 1
Fourth Military Medical University
Hunan Sheng, China
Patent: 1
Qingdao University
Shandong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: